Top Takes From RealMoney

The RealMoney contributors are in the business of trading and investing all day on the basis of ongoing news flow. Below, we offer the top five ideas that RealMoney contributors posted today and how they played those ideas.

TheStreet.com brings you the news all day, and with RealMoney's "Columnist Conversation," you can see how the pros are playing it on a real-time basis. Here are the top five ideas played today. To see all that RealMoney offers, click here for a free trial.

Penny Biotech Stocks Flying

By Adam Feuerstein
06/03/09 10:16 a.m.

We're living in some crazy, speculative times in penny-stock biotech land.

Cell Therapeutics(CTIC Quote), Hemispherx Biopharma(HEB Quote), Antigenics(AGEN Quote) and Oculus Innovative Sciences(OCLS Quote) are all flying higher in a whirlwind of speculative, retail and daytrading activity. All these companies have experimental drugs and/or products that are among the worst of the worst. Yet the stocks are extremely hard or expensive to borrow, and that is putting short-sellers in a bind.

Amazing.

---

Eyes on Bernanke's Bond Thoughts

By Marc Chandler
06/03/09 7:52 a.m.

The market will focus on Bernanke's House testimony today to see if he suggests the Fed is looking to increase the size of its Treasury purchases. Such an announcement is more likely at a FOMC meeting -- next scheduled: June 23-24 -- where there is full participation from the board.

After recouping a portion of recent losses, U.S. bonds are not out of line with global markets. This market settling may partly be due to Chinese, Japanese, Russian, Indian and South Korean officials reaffirming that the dollar will remain the world's reserve currency following rumors that BRIC countries are seeking otherwise.